Companies / Australia
If you would like to subscribe to Asia Pacific Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Asia Pacific Pharma & Healthcare Insight please click on the trial link below.
Reported Takeover Bid For Mayne Pharma
September 2006 | Company Finance AlertSorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Asia Pacific Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Asia Pacific Pharma & Healthcare Insight please click on the trial link below.
Australian drugmaker Mayne - which specialises in cancer treatments - has reportedly received a takeover bid of AUD2bn (US$1.5bn) from an unnamed multinational rival, according to local press reports. Speculation has rested on hospital supply company Hospira, which was spun off from US-based drugmaker Abbott Laboratories two years ago. Also mentioned as potential bidders, has been Israeli generics firm Teva and Swiss drug major Novartis.